INSIGHTS
-

Stop Before You Swallow – The Daily Pills Most People Shouldn’t Be Taking
Millions of Americans start their morning with a routine that feels healthy: a multivitamin, a fish oil capsule, maybe an extra vitamin D pill, and an over‑the‑counter pain reliever “just in case.” It feels proactive. It feels safe. But research shows that many of the medications and supplements people take every single day offer little
-

Common Food Preservatives Linked to Diabetes and Cancer
Food preservatives are everywhere. They help keep packaged foods fresh, prevent mold and bacteria, and extend shelf life. Without them, many grocery store staples wouldn’t last long enough to make it from factory to kitchen. But growing research suggests that some commonly used food preservatives may be linked to higher risks of serious health conditions,
-

FDA Requests Removal of Suicidal Behavior Warning from GLP‑1 Medications
Glucagon‑like peptide‑1 receptor agonists (GLP‑1 RAs) have become some of the most widely discussed medications in recent years – largely because of their role in weight loss and diabetes management. Drugs like Wegovy, Saxenda, and Zepbound have helped millions of people manage obesity and improve metabolic health. But until recently, these medications carried a warning
-

Levalbuterol Tartrate Uses, Safety, and Alternatives
Levalbuterol tartrate is an effective short‑acting bronchodilator for acute bronchospasm and is an alternative to albuterol. For most patients, clinical outcomes are similar between levalbuterol and albuterol; cost, individual tolerance, and device preference usually determine which product is best. Always use rescue inhalers as directed, maintain controller therapy when prescribed, and seek medical care for
-

FDA Approves Exdensur: A Twice‑Yearly Shot That Could Change Life for People with Severe Asthma
Severe asthma can be frightening: sudden attacks, emergency visits, and daily limits on what you can do. On December 16, 2025, the U.S. Food and Drug Administration (FDA) approved Exdensur (depemokimab‑ulaa) as an add‑on maintenance treatment for people aged 12 and older with severe asthma characterized by an eosinophilic phenotype – a type of asthma
-

FDA Expands Addyi Approval to Treat Postmenopausal Libido – What It Means and What to Know
Low sexual desire after menopause is common, and on December 15, 2025 the FDA expanded the label for Addyi (flibanserin) to include some postmenopausal women. This is a notable change: Addyi was first approved in 2015 for certain premenopausal women, and the new decision gives doctors another FDA‑cleared option for women under 65 who meet
-

Second Measles Surge of 2025: Why South Carolina’s Outbreak Is Accelerating and What You Need to Know
Measles is back in the headlines. After a major outbreak earlier this year, the United States is now seeing a second surge of measles cases, and one of the fastest-growing clusters is in South Carolina’s Upstate region. This post explains, in plain language, what’s happening, why it matters, and what you can do to protect
-

Coping with COPD: medications like tiotropium, how well they work, and the trade‑offs to expect
Living with COPD can feel like your lungs are always “on the edge.” The good news is there are medications that can open airways, reduce flare‑ups (exacerbations), and make daily life more manageable. This guide focuses on tiotropium (a common once‑daily inhaler) and similar treatments, explaining how they work, what studies say about benefits, and


